Zhong X, Kaul S, Eichler A, Bastert G
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical University, Wuhan 430030.
J Tongji Med Univ. 1999;19(3):181-4, 189. doi: 10.1007/BF02887729.
PCR enzyme linked immune sorbent assay (ELISA) was developed for detection of RT-PCR-amplified cytokeratin 19 (CK19) mRNA and carcinoembryonic antigen (CEA) mRNA. The non-radioactive hybridization was performed in a streptavidin-coated microwell with digoxigenin-labeled PCR products and with biotin-labeled capture probe. PCR ELISA was proved to be expedient, simple, sensitive and safe for identification of CK19-, CEA-RT-PCR products. These results were proven by sequencing.
聚合酶链反应酶联免疫吸附测定(ELISA)被开发用于检测逆转录聚合酶链反应(RT-PCR)扩增的细胞角蛋白19(CK19)信使核糖核酸(mRNA)和癌胚抗原(CEA)mRNA。非放射性杂交在链霉抗生物素蛋白包被的微孔中进行,使用地高辛标记的PCR产物和生物素标记的捕获探针。PCR ELISA被证明对于鉴定CK19 -、CEA - RT-PCR产物是方便、简单、灵敏且安全的。这些结果通过测序得到证实。